---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-022814"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2023-06-29T23:59:59+00:00"
generated_at: "2026-06-13T15:13:53.697936+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical raises $2M in registered direct offering; aggregate $7.6M from four offerings

## Summary
- Issued 624,618 shares of common stock at $3.25 per share in registered direct offering.
- Concurrent private placement of Series D warrants to purchase up to 312,309 shares at $3.19/share, exercisable for 5.5 years.
- Gross proceeds from this offering ~$2.0M; total from four recent closings ~$7.6M.
- Net proceeds to fund development of LIBERTY Robotic System, IP expansion, and working capital.
- H.C. Wainwright & Co. served as exclusive placement agent, receiving 7% cash fee and warrants.

## SEC filing metadata
- accession: 0001493152-23-022814
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2023-06-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315223022814/0001493152-23-022814-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315223022814/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-022814
- JSON: https://secwatch.observer/filing/0001493152-23-022814.json
- Plain text: https://secwatch.observer/filing/0001493152-23-022814.txt

## Key facts
- Material Agreements
  Microbot Medical Inc. entered into Securities Purchase Agreements with institutional investors valued at aggregate gross proceeds from the Offerings ... of approximately $2.0 million (effective 2023-06-26).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: institutional investors
  - Value: aggregate gross proceeds from the Offerings ... of approximately $2.0 million
  - Effective: 2023-06-26
  source text: On June 26, 2023, Microbot Medical Inc., a Delaware corporation (the “Company”), entered into Securities Purchase Agreements (the “Purchase Agreements”) with institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Registered Offering”), an aggregate of 624,618 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an offering price of $3.25 per share, for aggregate gross proceeds from the Offerings (as defined below) of approximately $2.0 million before deducting the placement agent fee (as described in greater detail below) and related offering expenses.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883975/000149315223022814/0001493152-23-022814-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.